I have two questions:
Are common antipsychotics like butyrophenones, diphenylbutylpiperidines or the tricyclic ones antagonists or inverse agonists at the dopamine receptors and how can this be distinguished? Do inverse agonists also cause desensitation or internalisation of the receptor?
Has anybody an idea?
Are common antipsychotics like butyrophenones, diphenylbutylpiperidines or the tricyclic ones antagonists or inverse agonists at the dopamine receptors and how can this be distinguished? Do inverse agonists also cause desensitation or internalisation of the receptor?
Has anybody an idea?